ID   M28N2
AC   CVCL_A4AT
DR   Wikidata; Q105509982
RX   PubMed=12602905;
CC   Characteristics: Weakly tumorigenic (PubMed=12602905).
CC   Doubling time: 37 hours (PubMed=12602905).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=Under the control of the promoter of rat Psbpc3/Scgb2a2).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: FVB-Tg(C3-1-TAg)cJeg/JegJ transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 27-11-25; Version: 7
//
RX   PubMed=12602905; DOI=10.1023/A:1021175931177;
RA   Holzer, Ryan G.
RA   MacDougall, Christina
RA   Cortright, Gerry
RA   Atwood, Kristi
RA   Green, Jeffrey E.
RA   Jorcyk, Cheryl Lynn
RT   "Development and characterization of a progressive series of mammary
RT   adenocarcinoma cell lines derived from the C3(1)/SV40 Large T-antigen
RT   transgenic mouse model.";
RL   Breast Cancer Res. Treat. 77:65-76(2003).
//